Walter David has 20+ years of experience in healthcare spanning early-stage R&D to in line product management across functional disciplines and disease areas. He is currently the Director of Research Business Development at City of Hope [CoH] where he supports search and evaluation efforts for the enterprise. He also helps manage CoH’s venture fund tasked with identifying promising early research with commercialization potential. Prior to CoH, he held various strategy and commercialization roles with different industry players [e.g., Amgen, Bayer Healthcare, others]. He holds a B.S./B.E. from New York University/Stevens Institute of Technology and an M.B.A. from Georgetown University.